Two New Drugs Help Relieve Sickle-Cell Disease. But Who Will Pay? by BY GINA KOLATA


Adakveo and Oxbryta could be revolutionary treatments, but each costs about $100,000 per year and must be taken for life.

Published: December 7, 2019 at 07:04PM

from NYT Health https://ift.tt/3520H25